# Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth

> **NCT03420976** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Atrium Innovations**

## Conditions studied

- Small Intestinal Bacterial Overgrowth

## Interventions

- **DIETARY_SUPPLEMENT:** Novel Supplement Based Therapy

## Key facts

- **NCT ID:** NCT03420976
- **Lead sponsor:** Atrium Innovations
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2017-12-07
- **Primary completion:** 2019-01-30
- **Final completion:** 2019-02-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI no longer in practice.
- **Last updated:** 2021-01-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03420976

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03420976, "Novel Supplement-based Therapy for the Treatment of Small Intestinal Bacterial Overgrowth". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03420976. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*